PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (SKIN + HAIR)
DRUG NAME: MINOXIDIL

• FDA Safety Data Sheet for topical minoxidil may be found here.

• Penha MA. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024 [PubMed Link]

• Ramos PM. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial. J Am Acad Dermatol. 2020 [PubMed Link]

• Stoehr JR. Off-Label Use of Topical Minoxidil in Alopecia: A Review. Am J Clin Dermatol. 2019 [PubMed Link]

• Gupta AK. Minoxidil: a comprehensive review. J Dermatolog Treat. 2022 [PubMed Link]

• Suchonwanit P. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019 [PubMed Link]

• Olsen EA A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002 [PubMed Link]

• Chen L. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. Aesthetic Plast Surg. 2020 [PubMed Link]

• Valentim FO. Efficacy of 5% topical minoxidil versus 5 mg oral biotin versus topical minoxidil and oral biotin on hair growth in men: randomized, crossover, clinical trial. An Bras Dermatol. 2024 [PubMed Link]

• Goren A. Minoxidil in the treatment of androgenetic alopecia. Dermatol Ther. 2018 [PubMed Link]

• Messenger AG. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004 [PubMed Link]

• Suchonwanit P. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018 [PubMed Link]